中文产业新闻评分27Chinese source
诺和诺德zenagamtide启动针对2型糖尿病、肥胖及超重人群的Ⅰ期临床试验
10月魔方TOP药企动态播报 | Novo Nordisk-zenagamtide启动一项 针对2型糖尿病,肥胖,超重的Phase I临床试验
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.